101-PGC-005 for the Treatment of COVID-19
Clinical trial NCT05656521 · UNKNOWN
Trial details
- NCT number
- NCT05656521
- Sponsor
- 101 Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2023-04-21
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.